What should Diabetics know about COVID-19?
COVID-19 is a highly infectious viral infection due to the Novel Coronavirus. The infection originated in Wuhan, China where it spread quickly. There are over 2,258,516 n people infected with the virus around the world and over 154,371 deaths. In India, there are 14,378 confirmed cases and 201 deaths. The virus is a new strain and countries around the world are unsure how to tackle and treat the virus.
The virus spreads via the droplets when an infected person coughs, sneezes, or talks. The virus can survive in the air and on solid surfaces for a few hours or days depending on the type of surface. If you touch a contaminated surface and then touch your nose, mouth, or eyes you can get infected. The virus is killed in the environment when the surface is wiped with an alcohol-based solution.
Most people experience mild to moderate symptoms and make a complete recovery. Symptoms of COVID-19 are:-
Muscle pain and headache
Fever
Dry Cough
Fatigue
Sore throat
Repeated shaking with chills
Loss of smell and taste
More severe symptoms may include:-
Pneumonia
Breathing difficulty
Diarrhea
Chest pain
Death
The World Health Organization has said patients with Type 1 or Type 2 diabetes are at a higher risk of serious infection if they contract the virus. People with diabetes have lower immunity levels. Your immune system protects you from infections. Diabetic patients may have other health problems such as high blood pressure, obesity, and heart disease. This will make you more susceptible to infections. Research showed that 22% of patients hospitalized in China with severe infections had diabetes.
Other than diabetes other high-risk categories are:-
cancer patients
Smokers
Bone marrow transplant or organ transplant patients.
Patients taking immune-suppression medications or steroids.
If you have AIDS or HIV.
Patients with chronic lung disease or you suffer from moderate or severe asthma.
Patients with chronic lung or kidney infections.
If you are over 65.
Your risks are higher if you don’t control your sugar levels. Higher sugar levels lower your immunity levels. Lower immunity levels make fighting the infection tougher. It is important to manage your diabetes more vigilantly in this period. Eat healthy meals, exercise indoors for at least 30 minutes. Exercise will improve your mental health as well. It is extremely important to have your medication on time. It is important to ensure you have insulin or glucose tablets handy. You can order your medicines at home in advance before your supply ends. You can monitor your sugar levels with blood tests at home or using a glucometer. Type 1 diabetic patients can either order urine tests or use urine ketone strips. If you feel your diabetic symptoms are worsening you can consult your doctor through video consultation.
It is extremely important to follow the precautions laid down by the government such as:-
Clean your hands with either soap or sanitizer frequently for at least 20 seconds.
Wear a mask when you are feeling unwell.
Sneeze or cough into tissues that must be disposed of properly.
Practice social distancing.
Clean and disinfect surfaces at home frequently.
Stay indoors as much as possible.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...
Continue Reading
Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...
Continue Reading
Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...
Continue Reading
Amgen Prepares to Reveal Third Quarter 2026 Financials If there's one thing I've learned about investing, it's that the devil's in the details, and Amgen's (NASDAQ:AMGN) upcoming webcast for its third quarter 2026 financial results is exactly the kind of detail that sets market-watchers' hearts racing. Scheduled for November 3, just after the U.S. markets close, this is...
Continue Reading
Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...
Continue Reading
Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...
Continue Reading
New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...
Continue Reading
Oracle Lays Down a Bold Gauntlet Oracle Corporation (NYSE: ORCL) sure knows how to draw the spotlight. With their recent Investor Day in Vegas, they've laid out ambitions that could make even the most seasoned Wall Streeter spit out their coffee. Who would've thought they'd be betting on a whopping $225 billion in revenue by FY30? That's supposed to be a more than 35%...
Continue Reading
Could This Be the Breakthrough for Portal Hypertension? Now, here's something that might just turn a few heads in the medical world. BD has launched their Liverty™ TIPS Stent Graft in the U.S., a move set to shake up the landscape for treating portal hypertension. This isn't just another shiny new gadget—it's a promise of more personalized patient care in a field...
Continue Reading
When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...
Continue Reading
Top 5 Most Recently Viewed Articles
The Expanding Landscape of the Automotive Key Blank Market The automotive key blank market is experiencing a transformative phase, poised to grow from USD 6.29 billion in 2025 to an impressive USD 9.67 billion by 2034. This remarkable growth reflects the industry’s ongoing adaptation to technological advancements, particularly the rising adoption of smart and automated...
Continue Reading
Insights into the Expanding Meat Processing Equipment Market The global meat processing equipment market is anticipated to experience significant growth, projected to reach USD 16.36 billion by 2032. This remarkable increase from its value of USD 11.25 billion in 2024 represents a robust compounded annual growth rate (CAGR) of 4.86% from 2025 to 2032. The factors driving...
Continue Reading
Fed's Waller Emphasizes Importance of Rate Cuts Christopher Waller, a Governor at the Federal Reserve, has spoken out about the economic challenges facing the labor market. He is advocating for a reduction in the Fed’s policy rate during the next meeting, scheduled for December. His approach centers on the need to address the risks associated with a weakening labor...
Continue Reading
Global Initiative on Ageing and Longevity Launches U.S. Chapter The Global Initiative on Ageing and Longevity (GIA-L) has propelled its mission forward by launching a North American Chapter. This initiative is designed to accelerate innovation and foster significant business growth while addressing the changing demographics and needs of an aging population. The GIA-L...
Continue Reading
Investigating Extreme Networks: What You Need to Know Faruqi & Faruqi, LLP, a well-known national securities law firm, is currently looking into possible claims on behalf of investors in Extreme Networks, Inc. (NASDAQ: EXTR). The firm is reaching out to investors who have incurred losses exceeding $100,000 to discuss their options and legal rights. With the situation...
Continue Reading